Abstract
Introduction

54
The melanocortin neuronal system plays a key role in regulating energy balance and metabolism 55 (11, 35) . This system is comprised of hypothalamic proopiomelanocortin (POMC) and agouti-56 related protein (AgRP) neurons whose peptide products interact with downstream melanocortin 57 receptor (MC-R) expressing neurons (16). The POMC-derived peptide α-MSH inhibits food 58 intake and stimulates energy expenditure while AgRP is an MC-R antagonist that stimulates food 59 intake and inhibits energy expenditure. Defects in POMC synthesis, peptide processing and in 60 MC-R signaling cause obesity in rodents and humans (4, 6, 31) . POMC and AgRP neurons are 61 responsive to a variety of metabolic signals that regulate energy and glucose homeostasis, 62 including leptin and insulin (17) . The physiology of this system has been extensively studied in 63 rodents but studies in humans are limited by the lack of biomarkers for brain POMC and AgRP.
64
Since levels of the intact POMC prohormone in cerebrospinal fluid (CSF) have been shown to 65 correlate with hypothalamic POMC in rodents, we have focused on similar measurements in 66 human CSF (23). Although it is the POMC-derived peptide α-MSH that engages brain MC-Rs,
67
CSF α-MSH levels are low and difficult to detect. In rodents, CSF POMC, rather then α- MSH, 68 has been show to reflect hypothalamic POMC activity (23). We have previously shown that high 69 levels of POMC are present in human CSF and that concentrations vary as a function of body 70 weight, adiposity and leptin (19). We found no correlation between CSF POMC and plasma
71
POMC which is of pituitary origin. We also measured AgRP in human CSF and plasma. In AgRP, leptin and other hormones in plasma in order to validate POMC and AgRP measurements 88 as biomarkers of melanocortin activity after acute and chronic caloric restriction and to examine 89 related changes in plasma and CSF leptin and sOB-R levels. ß-endorphin (ß-EP) was also 90 measured in CSF as both ß-EP and α-MSH are derived together from POMC and their levels in 91 the hypothalamus usually change in parallel (9, 13). Effects on insulin sensitivity and glucose 92 tolerance were studied as the melanocortin system can impact glucose metabolism independently 93 of changes in body weight (35).
95
Materials and Methods
96
Study participants and protocols
Study participants were healthy men and women (age 22-45 yrs) who were non-smokers and
98
were not taking medications. Women were studied in the early follicular phase of the menstrual 99 cycle. Subjects with a history of eating disorders, recent weight change ± 5%, or use of weight 100 loss products or dieting within 6 months of starting the study were excluded. This study was 101 approved by the Columbia University Institutional Review Board and written informed consent 102 was obtained from all subjects. Ten subjects (7 M, 3 F) were studied: 6 lean (BMI 23.1± 0.9 kg/m 2 ); 4 obese (BMI 33.0 ± 2.2).
106
Subjects were admitted to the clinical research center at 1000h (Day1), after fasting since dinner 107 at 1800h the previous day, and continued to fast for a total of 40h. They had free access to water One subject developed a mild headache after the first LP so did not have a second LP but was 119 refed and had blood drawn. 
Assays
130
Leptin and sOB-R were measured in plasma and CSF by ELISA (R&D Systems, Minneapolis, 131 MN) (19). POMC was measured by two-site ELISA (19, 27) ; no crossreactivity with ACTH, α-
132
MSH or ß-EP. ß-EP was measured by RIA as previously described; 3% crossreactivity with 133 POMC (25). ß-EP was also measured with a newly developed 2-site ELISA that is specific for 134 ß-EP and does not crossreact with POMC. This assay employs the same antibody used in the
135
RIA for capture and a monoclonal antibody (MAB5276, Millipore, Temecula, CA) to met-136 enkephalin (N-terminal of ß-EP) that was biotinylated for detection; sensitivity is 2 pg/ml. 
Study 1: Fasting and refeeding (RF)
161
Changes in leptin and sOB-R in plasma and CSF
162
Plasma leptin changed over time during fasting and RF (p<0.001) (Fig. 1) . Levels decreased 163 from baseline (upon admission) of 15.4 ± 5.1 to 6.1 ± 2.3 ng/ml after fasting (p=0.002) and then 164 increased to 20 ± 6.2 ng/ml during RF (p=0.02 vs baseline). Plasma leptin suppressed to 35.1 ± 165 3.4% of baseline in the entire group but the degree of suppression was more profound in lean vs.
166
obese subjects (28.7 ± 3.1 vs 44.8 ± 3.4% of baseline; p=0.009) (Fig. 1) . The peak percent 167 increase from baseline during RF was 173 ± 19 vs 130 ±17% in lean vs obese (p=0.16). CSF 168 leptin was 139 ± 41 pg/ml after fasting and increased to 205 ± 55 pg/ml after RF (p=0.004). The 169 percent increase in CSF leptin was greater in lean vs obese subjects (275± 56 vs 131 ± 5.7%; 170 p=0.016) (Fig. 1) . Thus relative changes in plasma and CSF leptin were more pronounced in 171 lean subjects after fasting and RF.
173
Plasma sOB-R increased over time during fasting and RF (p=0.004). Baseline sOB-R was 22.4 174 ± 2.0 ng/ml vs 23.3 ± 2.3 after fasting; levels continued to increase during RF to 25.7 ± 3.0 ng/ml 175 (p<0.05). The ratio of CSF to plasma leptin expressed as a percentage was 3.3 ± 0.48 % after 176 fasting and decreased to 1.9 ± 0.33 % after RF (p=0.008). Thus higher plasma sOB-R was 177 associated with a lower CSF to plasma leptin ratio. CSF sOB-R did not change significantly after 178 fasting vs RF (0.233 ±0.05 vs 0.256 ± 0.06 ng/ml; p=0.14).
179
Changes in insulin and ghrelin
180
Serum insulin decreased from 9.9 ± 2.5 to 5.4 ± 1.3 µIU/ml after 40h fasting (p=0.005). Plasma 181 ghrelin was 658 ± 91 and 657 ± 99 pg/ml after 16h and 24h fasting and tended to decrease after 182 40h (539 ± 72) fasting (p=0.09). Ghrelin then decreased after 3h and 8h of RF (63 and 51% of 183 baseline; p<0.001) and returned to 90% of baseline the following morning.
185
Changes in POMC and ß-EP in CSF and AgRP in CSF and plasma
186
The concentration of POMC in CSF was not different after fasting vs RF (p=0.49). In contrast 187 the concentration of ß-EP in CSF after fasting was 77.5% of the concentration after RF (p=0.04);
188
( Fig. 2) . The POMC to ß-EP ratio tended to be higher during fasting (p=0.11). CSF levels of Mean weight loss after 6 weeks of dieting was 8.6% (Fig. 3) . Plasma leptin decreased to 46% 207 (p=0.009) and CSF leptin to 70% of baseline (p= 0.004) (Fig. 3) . Plasma sOB-R increased to 2.1 to 9.2 ± 2.5 (p=0.02) (Fig. 5) . Fasting plasma ghrelin increased after weight loss (Fig. 3) and 
Changes in POMC and ß-EP in CSF and AgRP in CSF and plasma
222
The concentrations of POMC and ß-EP in CSF decreased significantly following weight loss.
223
Mean and individual changes are shown in Fig. 4 . CSF POMC decreased to 86% of baseline 224 (p=0.003). CSF ß-EP, measured by RIA and highly specific ELISA, decreased to 87% and 71% 225 of baseline respectively (p<0.05). There was no change in the POMC to ß-EP ratio. CSF AgRP 226 did not change after weight loss when measured by either ELISA (20.6 ±2.1 vs 19.0 ± 1.5 pg/ml) 227 or RIA (39.4 ± 6.8 vs 43.8 ± 6.0 pg/ml). However plasma AgRP increased significantly from 228 61.7 ± 9.7 to 72.0 ± 11 pg/ml (p=0.03) (Fig. 4) . The CSF POMC to plasma AgRP ratio 229 decreased to 74% of baseline (p=0.005); the CSF POMC to CSF AgRP (RIA) ratio decreased to 230 75% of baseline (p=0.01), indicating decreased melanocortin activity after weight loss.
232
At baseline, plasma AgRP correlated negatively with serum insulin (r= -0.807; p=0.008) and 233 HOMA (r= -0.633; p=0.13) (Fig. 5 ). There was a positive correlation between plasma AgRP and 234 the MI calculated during the baseline OGTT (r = 0.777; p=0.04) (Fig. 5) . These correlations 235 were no longer evident after weight loss. Subjects tended to report less hunger before the OGGT 236 done after weight loss (2.27±0.9) than before weight loss (4.5±1.0; p=0.05). There were no Plasma leptin fell to 35% of baseline after 40h of fasting and then rapidly rebounded after 24h of 258 RF. Relative changes in both plasma and CSF leptin were greater in lean vs the obese subjects,
259
suggesting that in lean individuals, the brain receives a more robust signal indicating energy 260 deficit and surplus. Changes in the CSF to plasma leptin ratio were compared after fasting and 261 RF. We hypothesized that the ratio would be lower during fasting due to increased sOB-R that 262 can inhibit leptin transport into brain (20, 28) . However the ratio was actually higher after 263 fasting vs RF which may be due to the fact that sOB-R levels continued to increase during RF.
264
By comparison, after dieting and achieving 8.6% weight loss, plasma and CSF leptin decreased 265 to 46% and 70% of baseline respectively but the CSF to plasma leptin ratio did not change 266 despite an increase in sOB-R levels. Weight loss during the fast was minimal compared to the 267 diet, but there was a comparable fall in leptin (3, 33).
269
The concentration of POMC in CSF did not change after 40h of fasting but decreased after given that levels of both peptides typically change in parallel (13, 32). As with POMC, CSF ß-
282
EP is of brain origin (25). Thus it is likely that the decline in CSF ß-EP during fasting is a 283 reflection of a decline in hypothalamic ß-EP and α-MSH. negative correlations between plasma AgRP and BMI and leptin in lean and obese subjects (19).
291
Similar negative correlations are again demonstrated. These results suggest that plasma AgRP is 292 of hypothalamic origin but how brain AgRP gains access to the circulation remains unclear.
293
Heavy AgRP fiber staining is found in the median eminence that could be a source of secretion 294 into the blood (7). Although the adrenals may also be a source for circulating AgRP (18) it is 295 notable that plasma AgRP did not change in rats after adrenalectomy (12). In contrast to plasma 296 AgRP, CSF AgRP did not increase significantly after fasting or dieting. The explanation for this 297 is unclear but may relate to anatomical differences in AgRP fiber tracks that gain access to CSF 298 and blood respectively (1, 7). However in CSF there was relatively more AgRP measured by 299 RIA vs ELISA after fasting. This is consistent with changes in AgRP processing resulting in 300 relatively more AgRP 83-132 which has more biological activity than the full-length peptide (5).
301
We have confirmed by HPLC that both forms of AgRP are present in CSF (19, 34).
302
AgRP neurons are known to play a role in responding to insulin signaling and regulating glucose 303 metabolism independent of changes in body weight (8, 24) . Plasma AgRP correlated negatively 304 with fasting insulin and HOMA in a cohort of lean and obese subjects and the correlation 305 persisted when adjusted for BMI (19) . This is again seen in the present studies. The negative 306 correlation observed at baseline in the diet study is notable given that it involved a more 307 homogeneous group of overweight/obese women. Furthermore, a strong positive correlation was 308 noted with plasma AgRP and the MI calculated during the baseline OGTT, providing more 309 evidence for the use of plasma AgRP as a marker of insulin sensitivity while weight stable.
310
However, these correlations were no longer evident during weight loss which is associated with 311 numerous hormonal and metabolic changes and an overall decrease in brain melanocortin 312 activity. 
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